RAPT
NASDAQ
$58.02
RAPT Therapeutics Inc (RAPT)
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$1.56B
FCF 5Y CAGR
+22.78%
Free Cash Flow Yield
-5.54%
Price Chart
Valuation
Market Cap$1.56B
Profitability
Gross Profit (TTM)$1.53M
EBITDA-$112M
EPS-$2.73
Financial Health
Free Cash Flow Yield-5.54%
Growth & Risk
FCF 5Y CAGR+22.78%
Sharpe Ratio2.12